• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Forms New Subsidiary AgeX Therapeutics, Inc. to Develop its Programs Focused on Human Aging

dr michael west biotime agex induced tissue regeneration

  • Please log in to reply
3 replies to this topic
⌛⇒ MITOMOUSE has been fully funded!

#1 alc

  • Validating
  • 208 posts
  • 101
  • Location:Columbus, OH
  • NO

Posted 07 April 2017 - 10:56 PM


"The mission of AgeX is to apply technology related to pluripotent stem cells and telomere biology to aging and age-related disease.

AgeX is expected to have three initial areas of focus:

1) the development of pluripotent stem cell-derived brown adipocytes for the treatment of Type II diabetes and potentially obesity;

2) the development of vascular progenitors to improve circulation to ischemic tissues in patients suffering from heart disease; and

3) Induced Tissue Regeneration (iTR)TM - an emerging technology invented and patented by BioTime scientists that is designed to profoundly reprogram aged tissues in the body in a way that can restore a regenerative phenotype normally expressed only in the first few weeks of human development."

 

http://investor.biot...news&id=2260328



#2 alc

  • Topic Starter
  • Validating
  • 208 posts
  • 101
  • Location:Columbus, OH
  • NO

Posted 08 April 2017 - 01:18 PM



#3 albedo

  • Guest
  • 1,396 posts
  • 430
  • Location:Europe
  • NO

Posted 23 July 2017 - 11:47 AM

Dr Aubrey de Grey appointed as VP New Technology Discovery of AgeX and nice interview on products to come:

 

 

(edit: adding link)


Edited by albedo, 23 July 2017 - 12:04 PM.


sponsored ad

  • Advert
Advertisements help to support the work of this non-profit organisation. [] To go ad-free join as a Member.

#4 ImmInst

  • Admin, Director robot
  • 2,196 posts
  • 60

Posted 03 August 2017 - 06:45 PM

AgeX Therapeutics Obtains $10 Million in Capital, Commences Operations
Patch.com - 53 minutes ago
ALAMEDA, CA - From AgeX Therapeutics via BusinessWire: AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc.

View the full article
  • Informative x 1





Also tagged with one or more of these keywords: dr michael west, biotime, agex, induced tissue regeneration

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users